In 2008, it was estimated that 24.7% of older adults with dementia living in the community were taking a cholinesterase inhibitor or memantine (hereafter referred to antidementia drugs) [3,4], at an average out-of-pocket cost of US $166 [5]. This evidence concerns the gene BCHE and dementia.